van Geel Nanja, Delbaere Liesbeth, Mertens Laura, Vandaele Virginie, Depaepe Lien, Van Causenbroeck Jérôme, De Schepper Sofie, Van Coile Laura, Van Reempts Astrid, De Vos Ann-Sophie, Papeleu Jorien, Hoorens Isabelle, Wolkerstorfer Albert, Speeckaert Reinhart
Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
Department of Dermatology, AZ Sint-Blasius, 9200 Dendermonde, Belgium.
J Clin Med. 2024 May 2;13(9):2680. doi: 10.3390/jcm13092680.
There is currently no guidance on how to interpret the global degrees of activity (worsening) and repigmentation (improvement) in vitiligo. Stratification into global degrees can be completed for static evaluations (e.g., visible disease activity signs) and dynamic assessments (e.g., evolution over time). For the latter, the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS) were recently validated. : In the current study, a Physician Global Assessment (PGA) for disease activity (worsening) and repigmentation (improvement) was evaluated for validity (construct) and reliability (inter- and intrarater) based on a photo set of 66 patients. Subsequently, the PGA activity (worsening) and repigmentation (improvement) were used to stratify the Vitiligo Extent Score plus (VESplus), VDAS or VDIS into three global categories (slightly, moderately and much worse/improved), based on ROC analysis. : For the VESplus, cut-off values for the categories 'slightly, moderately and much worse' were >0.3%, >27.71% and >128.75% BSA (relative changes in the affected total BSA), respectively. For the categories 'slightly, moderately and much improved', they were >0%, >4.87% and >36.88% BSA (relative changes in the affected total BSA), respectively. The optimal cut-off values of the number of active (VDAS) body areas were >0 areas for slightly worse, >2 areas for moderately worse and >7 for much worse. For VDIS, the cut-off values for slightly improved and moderately improved were >0 and >1. For VDAS and VDIS, the cut-off points were >0.5, >3, >9.5 and >0.5 and >1.5, respectively. The results should be interpreted with caution in patients with extensive vitiligo due to the rather limited disease extent of the included patient population (VESplus (median: 3.2%)). : This research will aid in the development of more detailed international definitions.
目前对于如何解读白癜风的整体活动度(恶化)和复色(改善)程度尚无指导意见。可针对静态评估(如可见的疾病活动体征)和动态评估(如随时间的演变)完成整体程度的分层。对于后者,白癜风疾病活动评分(VDAS)和白癜风疾病改善评分(VDIS)最近已得到验证。在本研究中,基于66例患者的照片集,对疾病活动(恶化)和复色(改善)的医师整体评估(PGA)进行了效度(结构效度)和信度(评分者间和评分者内)评估。随后,基于ROC分析,使用PGA活动度(恶化)和复色(改善)将白癜风面积评分升级版(VESplus)、VDAS或VDIS分为三个整体类别(轻度、中度和严重恶化/改善)。对于VESplus,“轻度、中度和严重恶化”类别的截断值分别为受累总体表面积(BSA)>0.3%、>27.71%和>128.75%(受累总BSA的相对变化)。对于“轻度、中度和明显改善”类别,截断值分别为受累总BSA>0%、>4.87%和>36.88%(受累总BSA的相对变化)。活动(VDAS)身体区域数量的最佳截断值为轻度恶化>0个区域、中度恶化>2个区域和严重恶化>7个区域。对于VDIS,轻度改善和中度改善的截断值分别为>0和>1。对于VDAS和VDIS,截断点分别为>0.5、>3、>9.5和>0.5、>1.5。由于纳入患者群体的疾病范围相当有限(VESplus(中位数:3.2%)),在广泛性白癜风患者中应谨慎解读这些结果。本研究将有助于制定更详细的国际定义。